Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Hematologic and Non-CRS Toxicities
Introduction Chimeric antigen receptor (CAR)–modified T-cell immunotherapy is highly effective for patients with relapsed and/or refractory B-cell malignancies, but significant adverse effects remain a concern. Systemic cytokine release syndrome (CRS) can occur in association with the inflammatory cytokine surge during…